UK Pharma Exports To Fall 22% In No-Deal Brexit
Third Countries Would Benefit From Europe’s Loss
A new report says that a free trade deal complete with a pharmaceutical mutual recognition agreement is needed to mitigate the damage Brexit will inflict on the global competitiveness of both the UK and the EU.
